Why the study?
A thorough understanding of how coronaviruses interact with host cell RNA-related posttranscriptional processes was needed to provide insights into viral pathogenesis and identify avenues for anti-coronaviral therapeutics.
Provides an in-depth perspective on how coronaviruses interact with host cell RNA biology machineries, offering insights for potential anti-coronaviral therapeutics.
Offers perspective on coronavirus RNA interactions; leaves open therapeutic targets for COVID-19-related cardiac complications.
Coronaviruses, including SARS-Cov-2, are RNA-based pathogens that interface with a large variety of RNA-related cellular processes during infection. These processes include capping, polyadenylation, localization, RNA stability, translation, and regulation by RNA binding proteins or noncoding RNA effectors. The goal of this article is to provide an in-depth perspective on the current state of knowledge of how various coronaviruses interact with, usurp, and/or avoid aspects of these cellular RNA biology machineries. A thorough understanding of how coronaviruses interact with RNA-related posttranscriptional processes in the cell should allow for new insights into aspects of viral pathogenesis as well as identify new potential avenues for the development of anti-coronaviral therapeutics. This article is categorized under: RNA in Disease and Development > RNA in Disease.
No takes yet. Share an insight, caveat, or question.
Maranon et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: